169264 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor for cancer; Specifically defined cancers of skin, e.g. melanoma
Phosphopeptides as melanoma vaccines
#302Flap Endonuclease-1 As A Marker For Cancer
#303USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
#304DETECTING CANCER WITH ANTI-CXCL13 AND ANTI-CXCR5 ANTIBODIES
#305Methods of predicting clinical outcome in malignant melanoma
#306Probes and methods of melanoma imaging
#307METHODS OF DIAGNOSIS AND TREATMENT OF MELANOMA
#308Insulin-like growth factor binding protein 7 for treatment of cancer
#309Method and compositions for inhibiting tumorigenesis
#310DETECTING CANCER WITH ANTI-CXCL16 AND ANTI-CXCR6 ANTIBODIES
#311Compositions and methods for detecting cancer metastasis
#312Use of myeloid cell biomarkers for the diagnosis of cancer
#313COMPOSITIONS AND METHODS FOR TREATING CANCER AND METHODS FOR PREDICTING A RESPONSE TO SUCH TREATMENTS
#314Method and a Kit To Detect Malignant Tumors and Provide a Prognosis
#315Means and Method for Ovarian Cancer Prognosis
#316Method to treat melanoma in BRAF inhibitor-resistant subjects
#317Prediction of response to platinum-based therapy
#318gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
#319Diagnosis and treatment of cancer
#320METHOD OF PREDICTING CLINICAL OUTCOMES FOR MELANOMA PATIENTS USING CIRCULATING MELANOMA CELLS IN BLOOD
#321IL-8 biomarker for monitoring cancer treatment with certain ERK inhibitors
#322THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#323Methods for predicting survival in metastatic melanoma patients
#324METHODS AND SYSTEMS FOR TISSUE PROCESSING AND IMAGING
#325METHODS FOR DIAGNOSIS AND PROGNOSIS OF CANCER
#326Melanoma antigen peptide and uses thereof
#327B7-H3 AS A BIOMARKER FOR DIAGNOSING THE PROGRESSION AND EARLY LYMPH NODE METASTASIS OF CANCER
#328Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
#329Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors
#330FULL LENGTH LARGE T TUMOR ANTIGEN OF MERKEL CELL POLYOMAVIRUS AS A THERAPEUTIC TARGET IN MERKEL CELL CARCINOMA
#331USE OF CCR9, CCL25/TECK, AND INTEGRIN ALPHA4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE
#332USE OF CCR9, CCL25/TECK, AND INTEGRIN ALPHA4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE
#333DIAGNOSIS METHOD AND DIAGNOSIS KIT FOR DERMATOMYOSITIS
#334USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
#335MOLECULAR DIAGNOSIS AND CLASSIFICATION OF MALIGNANT MELANOMA
#336USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
#337TUMOR SUPPRESSION THROUGH PLEXIN C1
#338MDA-7 PROTEINS AND METHODS OF USE THEREOF
#339Use of Activating Transcription Factor-2 (ATF2) for Detecting Skin Cancer
#340Molecular diagnosis and classification of malignant melanoma
#341MELANOMA BIOMARKER AND METHODS OF USES
#342Biomarker for identification of melanoma tumor cells
#343REPLICATION PROTEIN
#344GAB2 AMPLIFICATION IN MELANOMA
#345Upregulation of rack-1 in melanoma and its use as a marker
#346HER3 AS A DETERMINANT FOR THE PROGNOSIS OF MELANOMA
#347Compounds and methods for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
#348Method for detecting disease markers
#349CCL18 and CCL3 methods and compositions for detecting and treating cancer
#350Molecular profiling of tumors
#351Variants of humanized anti-carcinoma MAb CC49
#352Upregulation of RACK-1 in melanoma and its use as a marker
#353Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic Use
#354Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
#355Method for Detection of Melanoma
#356Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
#357Methods of diagnosing cancer
#358Cancer diagnostic kit and cancer diagnostic method
#359USE OF RUNX3 AND MIR-532-5P AS CANCER MARKERS AND THERAPEUTIC TARGETS
#360Cancer Classification and Methods of Use
#361Method for detecting cancer and reagents for use therein
#362Breast tumor treatment with anti-CXCR1 compositions
#363PROSTATE CANCER AND MELANOMA ANTIGENS
#364Use of Semenogelin in the Diagnosis, Prognosis and Treatment of Cancer
#365Methods of Inhibiting Tumor Cell Aggressiveness Using the Microenvironment of Human Embryonic Stem Cells
#366MELANOMA REPOPULATING CELLS
#367Method and compositions for inhibiting tumorigenesis
#368Use of melanoma inhibitory activity (MIA) protein as an early indicator for therapeutic response in melanoma
#369BIOMARKERS OF TARGET MODULATION, EFFICACY, DIAGNOSIS AND/OR PROGNOSIS FOR RAF INHIBITORS
#370MDA-7 PROTEINS AND METHODS OF USE THEREOF
#371UHRF1 DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#372TTK DIRECTED DIAGNOSTICS FOR NEOPLASTIC DISEASE
#373Method to measure and characterize microvesicles in the human body fluids
#374Melanoma biomarker and methods of uses
#375and genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma
#376Polynucleotide fragments of an infectious human endogenous retrovirus
#377METHODS FOR TREATING MITF-RELATED DISORDERS
#378Cytotoxicity mediation of cells evidencing surface expression of CD63
#379Insulin-like growth factor binding protein 7 for treatment of cancer
#380Automated Enumeration and Characterization of Circulating Melanoma Cells in Blood
#381Melanoma-associated endogenous retrovirus (MERV) derived peptide sequences and their therapeutic/diagnostic use
#382Diagnostic kit for malignant melanoma
#383UPREGULATION OF RACK-1 IN MELANOMA AND ITS USE AS A MARKER
#384Cytotoxicity mediation of cells evidencing surface expression of MCSP
#385Method for Detection of L523S Expression in Biological Samples
#386Intercellular adhesion molecules and their binding ligands
#387USE OF CCR9, CCL25/TECK, AND NITEGRIN alpha4 IN DIAGNOSIS AND TREATMENT OF MELANOMA METASTASIS IN THE SMALL INTESTINE
#388FUNCTIONAL TOLL-LIKE RECEPTORS (TLR) ON MELANOCYTES AND MELANOMA CELLS AND USES THEREOF
#389Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods
#390Methods and Materials for Examining the P13k/Akt Pathway in Gliomas and Prostate Cancers
#391Melanoma antigens and their use in diagnostic and therapeutic methods
#392Melanoma antigens and their use in diagnostic and therapeutic methods
#393Melanoma antigens and their use in diagnostic and therapeutic methods
#394Animal model, cells, and treatment for malignant melanoma
#395PIK4CA as modifier of the Rac pathway and methods of use
#396Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
#397Antigen Specific Lymphocytes, Compositions Thereof, and Methods for Isolation and Preparation Thereof
#398Prostate cancer and melanoma antigens
#399CLASS II HISTONE DEACETYLASE WHOLE CELL ENZYME ASSAY
#400Method for Detection of Melanoma
#401Biomarkers for melanoma
#402TEL/Etv6-mediated inhibition of cell proliferation
#403Variants of humanized anti-carcinoma MAb CC49
#404Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells
#405Diagnostic agent for malignant melanoma
#406Cytotoxicity mediation of cells evidencing surface expression of CD63
#407Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
#408Melanoma antigens and their use in diagnostic and therapeutic methods
#409Melanoma antigens and their use in diagnostic and therapeutic methods
#410SPARC and methods of use thereof
#411Method for detection and characterization of pre-malignant transformation
#412Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases
#413Novel nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecles, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor
#414System and method for enhancing confocal reflectance images of tissue specimens
#415Mammalian IAP gene family, primers, probes and detection methods
#416Mammalian IAP gene family, primers, probes and detection methods
#417Mammalian IAP gene family, primers, probes and detection methods
#418Mammalian IAP gene family, primers, probes and detection methods
#419Mammalian IAP gene family, primers, probes and detection methods
#420Novel protein related to melanoma-inhibiting protein and uses thereof
#421Mammalian IAP gene family, primers, probes and detection methods
#422Mammalian IAP gene family, primers, probes and detection methods
#423Mammalian IAP gene family, primers, probes and detection methods
#424Cytotoxicity mediation of cells evidencing surface expression of CD63
#425Diaryl ureas with kinase inhibiting activity
#426Mammalian IAP gene family, primers, probes, and detection methods
#427Methods and compositions for inhibiting tumorigenesis
#428Mediators of epithelial adhesion and their role in cancer and skin disorders
#429Id-1 and Id-2 genes and products as markers of epithelial cancer
#430Methods for detecting vasculopathies and tumors
#431Cytotoxicity mediation of cells evidencing surface expression of CD63
#432Mammalian IAP gene family, primers, probes and detection methods
#433Cytotoxicity mediation of cells evidencing surface expression of CD63
#434Ptprk immunogenic peptide
#435Replication protein
#436Use of the slug gene, or of the transcription or expression products thereof in the detection and/or treatment of cancerous cells
#437TAG-1 and TAG-2 proteins and uses thereof
#438Mammalian IAP gene family, primers, probes, and detection methods
#439Multi-antigen vectors of melanoma
#440DAP-10 and uses thereof
#441Antibodies to a polypeptide encoded by a nucleic acid underexpressed in melanoma
#442Rabs as modifiers of the p53 pathway and methods of use
#443Use of microphthalmia for diagnosis, prognosis and/or treatment of melanoma
#444Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof
#445Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor
#446Variants of humanized anti-carcinoma monoclonal antibody CC49
#447Method and compositions for inhibiting tumorigenesis
#448Method and compositions for inhibiting tumorigenesis
#449Peptides of melanoma antigen and their use in diagnostic, prophylactic and therapeutic methods
#450Cytotoxicity mediation of cells evidencing surface expression of MCSP
#451Diaryl ureas for diseases mediated by PDGFR
#452Laminin chains: diagnostic and therapeutic use
#453Imaging mass spectrometry and uses thereof